TY  - GEN
AU  - Li,Rui
AU  - Chowdhury,Mohammed Y E
AU  - Kim,Jae-Hoon
AU  - Kim,Tae-Hwan
AU  - Pathinayake,Prabuddha
AU  - Koo,Wan-Seo
AU  - Park,Min-Eun
AU  - Yoon,Ji-Eun
AU  - Roh,Jong-Bok
AU  - Hong,Seung-Pyo
AU  - Sung,Moon-Hee
AU  - Lee,Jong-Soo
AU  - Kim,Chul-Joong
TI  - Mucosally administered Lactobacillus surface-displayed influenza antigens (sM2 and HA2) with cholera toxin subunit A1 (CTA1) Induce broadly protective immune responses against divergent influenza subtypes
SN  - 1873-2542
PY  - 2016///0405
KW  - Adjuvants, Immunologic
KW  - Administration, Intranasal
KW  - Animals
KW  - Antigens, Surface
KW  - immunology
KW  - Cholera Toxin
KW  - Cross Protection
KW  - Drug Evaluation, Preclinical
KW  - Immunity, Cellular
KW  - Influenza A Virus, H1N1 Subtype
KW  - Influenza A Virus, H3N2 Subtype
KW  - Influenza A Virus, H5N1 Subtype
KW  - Influenza A Virus, H5N2 Subtype
KW  - Influenza A Virus, H9N2 Subtype
KW  - Influenza A virus
KW  - genetics
KW  - Influenza Vaccines
KW  - Interleukin-4
KW  - Lactobacillus
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Orthomyxoviridae Infections
KW  - prevention & control
KW  - Republic of Korea
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.vetmic.2015.07.020
ER  -